Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 241 results
Press release cover image

Oct 29, 2026

Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology

Licensable perturbation dataset to include transcriptomes and proteomic secretomes for understanding the human immune responseSEATTLE & MONTREAL--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single-cell sequencing and a QIAGEN company, and Nomic Bio, a leader in high throughput proteomic profiling, today announced their partnership to generate Cascade, a 100 Million cell foundational dataset to understand the human immune response. The dataset's scale a
Press release cover image

Oct 28, 2026

Dyno Therapeutics to Present New AAV Capsid Data Across Three Posters at the 33rd Annual Congress of the European Society of Gene & Cell Therapy

Posters detail new dual-mechanism muscle capsids, a cross-species capsid targeting alkaline phosphatase for CNS and muscle delivery, and a systematic approach to engineering antibody-evasive capsids across mechanismsWATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve in vivo gene delivery, today announced new preclinical data on its AI-engineered adeno-associated virus (AAV) capsid platform in three poster pres
Press release cover image

Oct 27, 2026

KROMATID Selected as Industry Resource Partnership Program Member by the California Institute for Regenerative Medicine (CIRM)

Expands access to high-resolution, single-cell genomic analysis throughout cell and gene therapy developmentBOULDER, Colo., Oct. 27, 2026 /PRNewswire/ -- KROMATID, a leader in analytical cytogenetics for the cell and gene therapy industry, announced today it has been selected to be a member of the Industry Resource Partnership (IRP) program by the California Institute for Regenerative Medicine (CIRM).CIRM's Industry Resource Partnership (IRP) program streamlines collaboration and knowledge shari
Press release cover image

Oct 27, 2026

Fios Genomics bioinformatics team and services move to Excelra

Edinburgh-based team joins Excelra's scientific consulting group, strengthening its omics analytics expertise and presence in the UK and EuropeEDINBURGH, Scotland and HYDERABAD, India, Oct. 27, 2026 /PRNewswire/ -- Excelra, a global scientific informatics company, today announced that the bioinformatics services of Fios Genomics Ltd, and the team behind them, have moved to Excelra with effect from 20 October 2026.Continue Reading Fios Genomics, based in Edinburgh, has spent nearly two decad
Tissue sample in a petri dish on a lab bench

Oct 27, 2026

Single-Cell Multiomics: Phenotypic Plasticity in Colorectal Cancer Metastasis

Recent advancements in single-cell multiomics and spatial transcriptomics are shedding light on the phenotypic plasticity of colorectal cancer (CRC), which plays a crucial role in tumor progression and metastasis.In an upcoming webinar, Dr. Mirjana Efremova from Queen Mary University of London will explore how these innovative technologies can be applied to analyze both primary and metastatic CRC samples. The findings suggest that certain cancer cell states—specifically regenerative and inflamma
A minimalist representation of a chromosome highlighting genomic alterations in hematologic cancers.

Oct 27, 2026

ASHG: Nabsys Links Cytogenetics and Genomics to Map Hematologic Cancers

Nabsys is leveraging its Electronic Genome Mapping (EGM) technology to enhance the detection of genomic alterations in hematologic cancers, addressing the limitations of traditional assays.Hematologic malignancies often involve complex genomic rearrangements such as translocations and deletions that current diagnostic methods struggle to capture comprehensively. Characterization typically requires a combination of techniques like karyotyping and sequencing, each with inherent limitations. At the
A vaccine vial on a laboratory bench

Oct 27, 2026

NEC powers AI vaccine design in EU’s PREPAIR VAC project

NEC Corporation is set to enhance pandemic preparedness through its participation in the PREPAIR VAC project, a Horizon Europe initiative focused on AI-driven vaccine design.The PREPAIR VAC project, which will run for four years starting in September 2026 with a budget of around €6.5 million, aims to tackle significant challenges in vaccine development. This collaborative effort includes NEC OncoImmunity AS, a subsidiary of NEC Bio, and various European partners from academia, industry, and publ
DNA helix and immune cell silhouette

Oct 27, 2026

ParkourSC Acquires Quartic, PacBio Partners with Verily, CAS Data Arrives in Microsoft Copilot

Recent developments in the life sciences highlight significant collaborations and innovations aimed at enhancing drug discovery and genomic research.Carterra and AstraZeneca are joining forces to advance lab-in-the-loop drug discovery methodologies, while Ultima Genomics has secured a pivotal role in an extensive immune profiling study utilizing the UK Biobank's resources. This study aims to leverage advanced sequencing technologies to analyze immune responses across a large cohort. Additionally
A test tube with a biological sample in a dimly lit lab setting.

Oct 26, 2026

World HUPO 2026: Asia-Pacific Ambition and the Road to Predictive Biology

The World HUPO 2026 congress in Singapore showcased a vibrant intersection of proteomics, technology, and collaborative ambition, emphasizing predictive biology's potential.The event attracted 1,428 participants from 45 nations, under the theme “Proteomics Plus: Transforming Lives.” Discussions transcended traditional proteomics, focusing on broader questions about disease prediction and treatment efficacy. The agenda included workshops, competitions for early-career researchers, and an interact
A minimalist representation of a cancer cell in a tumor ecosystem.

Oct 26, 2026

Spatial Proteomics for Precision Oncology

Recent advancements in spatial proteomics, particularly through imaging mass cytometry (IMC), are transforming precision oncology by enhancing our understanding of tumor ecosystems.Dr. Bernd Bodenmiller, a leading figure in quantitative biomedicine at the University of Zürich, has been instrumental in developing innovative techniques to analyze the complex interactions within tumor environments. His research focuses on how the spatial arrangement and diversity of cancer cell phenotypes influence
Press release cover image

Oct 26, 2026

Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The certification covers Tempus’ quality management system for "next-generation sequencing devices for cancer genomic profiling to support clinical management."xR detects gene rearrangements and specific splice variants in solid tumor tissue to support clinical management. A p
Press release cover image

Oct 26, 2026

More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds

PALO ALTO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- New research from 23andMe Research Institute shows that more than one in 10 people who received 23andMe Genetic Health Risk reports learned they have a genetic variant linked to a condition with established options for screening or prevention. The findings were presented by Chief Medical Officer Dr. Noura Abul-Husn at the American Society of Human Genetics (ASHG) 2026 Annual Meeting last week in Montréal. 23andMe researchers analyzed results